E. Olavi Kajander

2.6k total citations
52 papers, 1.9k citations indexed

About

E. Olavi Kajander is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Ecology. According to data from OpenAlex, E. Olavi Kajander has authored 52 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Ecology. Recurrent topics in E. Olavi Kajander's work include Kidney Stones and Urolithiasis Treatments (9 papers), Microbial Community Ecology and Physiology (7 papers) and Polyamine Metabolism and Applications (7 papers). E. Olavi Kajander is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (9 papers), Microbial Community Ecology and Physiology (7 papers) and Polyamine Metabolism and Applications (7 papers). E. Olavi Kajander collaborates with scholars based in Finland, United States and Germany. E. Olavi Kajander's co-authors include Neva Çiftçioğlu, Terho O. Eloranta, Aarne Raina, Kim Bergström, Mikael Björklund, J. Thomas Hjelle, Alpo Pelttari, Ilpo Kuronen, Erkki Raulo and Riitta Nolo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Geochimica et Cosmochimica Acta.

In The Last Decade

E. Olavi Kajander

52 papers receiving 1.8k citations

Peers

E. Olavi Kajander
Robert A. Weisman United States
W.F. Neuman United States
Trump Bf United States
E. Olavi Kajander
Citations per year, relative to E. Olavi Kajander E. Olavi Kajander (= 1×) peers Neva Çiftçioğlu

Countries citing papers authored by E. Olavi Kajander

Since Specialization
Citations

This map shows the geographic impact of E. Olavi Kajander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Olavi Kajander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Olavi Kajander more than expected).

Fields of papers citing papers by E. Olavi Kajander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Olavi Kajander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Olavi Kajander. The network helps show where E. Olavi Kajander may publish in the future.

Co-authorship network of co-authors of E. Olavi Kajander

This figure shows the co-authorship network connecting the top 25 collaborators of E. Olavi Kajander. A scholar is included among the top collaborators of E. Olavi Kajander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Olavi Kajander. E. Olavi Kajander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kajander, E. Olavi. (2006). Nanobacteria - propagating calcifying nanoparticles. Letters in Applied Microbiology. 0(0). 1809223250–???. 59 indexed citations
2.
Sommer, Andrei P., Uri Oron, D. S. McKay, et al.. (2003). A Preliminary Investigation into Light-Modulated Replication of Nanobacteria and Heart Disease. Journal of Clinical Laser Medicine & Surgery. 21(4). 231–235. 17 indexed citations
3.
Kajander, E. Olavi, et al.. (2003). Characteristics of nanobacteria and their possible role in stone formation. Urological Research. 31(2). 47–54. 74 indexed citations
4.
Hjelle, J. Thomas, et al.. (2002). Inhibition of Nanobacteria by Antimicrobial Drugs as Measured by a Modified Microdilution Method. Antimicrobial Agents and Chemotherapy. 46(7). 2077–2086. 61 indexed citations
5.
Kajander, E. Olavi, et al.. (2001). Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease. Current Opinion in Nephrology & Hypertension. 10(3). 445–452. 53 indexed citations
6.
Koistinen, Kaisa M., et al.. (2000). Monoclonal Antibodies to Specific Surface Antigens on Gremmeniella abietina Spores. Mycologia. 92(3). 421–421. 2 indexed citations
7.
Poxton, Ian R., E. Olavi Kajander, Neva Çiftçioğlu, et al.. (2000). Endotoxin and nanobacteria in polycystic kidney disease. Kidney International. 57(6). 2360–2374. 82 indexed citations
8.
Kajander, E. Olavi & Neva Çiftçioğlu. (1999). Nanobacteria: An Alternative Mechanism for Pathogenic Intra- and Extracellular Calcification and Stone Formation. The Journal of Urology. 161(5). 1735–1735. 19 indexed citations
9.
Çiftçioğlu, Neva, et al.. (1999). Nanobacteria: An infectious cause for kidney stone formation. Kidney International. 56(5). 1893–1898. 160 indexed citations
10.
Çiftçioğlu, Neva, et al.. (1998). <title>Sedimentary rocks in our mouth: dental pulp stones made by nanobacteria</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 3441. 130–136. 26 indexed citations
11.
Åkerman, Kari, Jyrki T. Kuikka, Neva Çiftçioğlu, et al.. (1997). Radiolabeling and in vivo distribution of nanobacteria in rabbit. 3111. 436–442. 5 indexed citations
12.
Kajander, E. Olavi, et al.. (1997). <title>Nanobacteria from blood: the smallest culturable autonomously replicating agent on Earth</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 3111. 420–428. 93 indexed citations
13.
Uotila, Antti, et al.. (1996). Two types of the European race of Gremmeniella abietina can be identified with immunoblotting. Mycologia. 88(4). 619–625. 13 indexed citations
14.
Harvima, Rauno J., E. Olavi Kajander, Ilkka T. Harvima, et al.. (1993). Screening of effects of selenomethionine/enriched yeast supplementation on various immunological and chemical parameters of skin and blood in psoriatic patients.. Acta Dermato Venereologica. 73(2). 88–91. 22 indexed citations
15.
Kajander, E. Olavi, et al.. (1992). Detection of xylan hydrolyzing activity in culture extracts of Gremmeniella abietina. European Journal of Forest Pathology. 22(6-7). 349–353. 8 indexed citations
16.
Kajander, E. Olavi, Rauno J. Harvima, Terho O. Eloranta, et al.. (1991). Metabolism, cellular actions, and cytotoxicity of selenomethionine in cultured cells. Biological Trace Element Research. 28(1). 57–68. 47 indexed citations
17.
Harvima, Rauno J., et al.. (1989). Effect of drugs on histamine radio-enzyme assay. Clinica Chimica Acta. 180(3). 231–239. 4 indexed citations
18.
Carson, Dennis A., Tsutomu Nobori, E. Olavi Kajander, et al.. (1988). Methylthioadenosine (MeSAdo) Phosphorylase Deficiency in Malignancy. Advances in experimental medicine and biology. 250. 179–185. 5 indexed citations
19.
Kubota, Masaru, E. Olavi Kajander, & Dennis A. Carson. (1985). Independent regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in methylthioadenosine phosphorylase-deficient malignant murine lymphoblasts.. PubMed. 45(8). 3567–72. 11 indexed citations
20.
Harvima, Rauno J., et al.. (1984). Histamine N-methyltransferase preparation used for histamine assay contains endogenous histamine. Clinica Chimica Acta. 143(3). 337–341. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026